XOMA Co. (NASDAQ:XOMAO – Get Free Report) saw a significant growth in short interest in May. As of May 29th, there was short interest totaling 2,149 shares, a growth of 1,468.6% from the May 14th total of 137 shares. Based on an average trading volume of 4,591 shares, the short-interest ratio is currently 0.5 days.
XOMA Price Performance
Shares of XOMAO traded up $0.01 during mid-day trading on Tuesday, hitting $25.37. 890 shares of the company’s stock were exchanged, compared to its average volume of 3,926. XOMA has a fifty-two week low of $24.86 and a fifty-two week high of $26.40. The business’s 50 day moving average is $25.44 and its two-hundred day moving average is $25.42.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
See Also
- Five stocks we like better than XOMA
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
